Literature DB >> 23039893

Bead-size directed distribution of Pseudomonas aeruginosa results in distinct inflammatory response in a mouse model of chronic lung infection.

L J Christophersen1, H Trøstrup, D S Malling Damlund, T Bjarnsholt, K Thomsen, P Ø Jensen, H P Hougen, N Høiby, C Moser.   

Abstract

Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis (CF) patients is characterized by biofilms, tolerant to antibiotics and host responses. Instead, immune responses contribute to the tissue damage. However, this may depend on localization of infection in the upper conductive or in the peripheral respiratory zone. To study this we produced two distinct sizes of small alginate beads (SB) and large beads (LB) containing P. aeruginosa. In total, 175 BALB/c mice were infected with either SB or LB. At day 1 the quantitative bacteriology was higher in the SB group compared to the LB group (P < 0·003). For all time-points smaller biofilms were identified by Alcian blue staining in the SB group (P < 0·003). Similarly, the area of the airways in which biofilms were identified were smaller (P < 0·0001). A shift from exclusively endobronchial to both parenchymal and endobronchial localization of inflammation from day 1 to days 2/3 (P < 0·05), as well as a faster resolution of inflammation at days 5/6, was observed in the SB group (P < 0·03). Finally, both the polymorphonuclear neutrophil leucocyte (PMN) mobilizer granulocyte colony-stimulating factor (G-CSF) and chemoattractant macrophage inflammatory protein-2 (MIP-2) were increased at day 1 in the SB group (P < 0·0001). In conclusion, we have established a model enabling studies of host responses in different pulmonary zones. An effective recognition of and a more pronounced host response to infection in the peripheral zones, indicating that increased lung damage was demonstrated. Therefore, treatment of the chronic P. aeruginosa lung infection should be directed primarily at the peripheral lung zone by combined intravenous and inhalation antibiotic treatment.
© 2012 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23039893      PMCID: PMC3482369          DOI: 10.1111/j.1365-2249.2012.04652.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

Review 1.  Mucus clearance as a primary innate defense mechanism for mammalian airways.

Authors:  Michael R Knowles; Richard C Boucher
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

2.  In vivo imaging of the bronchial wall microstructure using fibered confocal fluorescence microscopy.

Authors:  Luc Thiberville; Sophie Moreno-Swirc; Tom Vercauteren; Eric Peltier; Charlotte Cavé; Genevieve Bourg Heckly
Journal:  Am J Respir Crit Care Med       Date:  2006-10-05       Impact factor: 21.405

Review 3.  Neutrophil recruitment to the lungs during bacterial pneumonia.

Authors:  Ann Craig; John Mai; Shanshan Cai; Samithamby Jeyaseelan
Journal:  Infect Immun       Date:  2008-11-17       Impact factor: 3.441

4.  Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients.

Authors:  Dieter Worlitzsch; Robert Tarran; Martina Ulrich; Ute Schwab; Aynur Cekici; Keith C Meyer; Peter Birrer; Gabriel Bellon; Jürgen Berger; Tilo Weiss; Konrad Botzenhart; James R Yankaskas; Scott Randell; Richard C Boucher; Gerd Döring
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

5.  Mucosal immunity to Pseudomonas aeruginosa alginate in cystic fibrosis.

Authors:  S S Pedersen; H Møller; F Espersen; C H Sørensen; T Jensen; N Høiby
Journal:  APMIS       Date:  1992-04       Impact factor: 3.205

6.  Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia.

Authors:  P Ø Jensen; C Moser; A Kharazmi; T Presler; C Koch; N Høiby
Journal:  J Cyst Fibros       Date:  2006-02-28       Impact factor: 5.482

7.  Chronic Pseudomonas aeruginosa lung infection is more severe in Th2 responding BALB/c mice compared to Th1 responding C3H/HeN mice.

Authors:  C Moser; H K Johansen; Z Song; H P Hougen; J Rygaard; N Høiby
Journal:  APMIS       Date:  1997-11       Impact factor: 3.205

8.  Improved outcome of chronic Pseudomonas aeruginosa lung infection is associated with induction of a Th1-dominated cytokine response.

Authors:  C Moser; P O Jensen; O Kobayashi; H P Hougen; Z Song; J Rygaard; A Kharazmi; N H by
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

9.  Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.

Authors:  Thomas Bjarnsholt; Peter Østrup Jensen; Mark J Fiandaca; Jette Pedersen; Christine Rønne Hansen; Claus Bøgelund Andersen; Tacjana Pressler; Michael Givskov; Niels Høiby
Journal:  Pediatr Pulmonol       Date:  2009-06

10.  Novel experimental Pseudomonas aeruginosa lung infection model mimicking long-term host-pathogen interactions in cystic fibrosis.

Authors:  Claus Moser; Maria Van Gennip; Thomas Bjarnsholt; Peter Østrup Jensen; Baoleri Lee; Hans Petter Hougen; Henrik Calum; Oana Ciofu; Michael Givskov; Søren Molin; Niels Høiby
Journal:  APMIS       Date:  2009-02       Impact factor: 3.205

View more
  10 in total

1.  Polymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients.

Authors:  Kasper N Kragh; Morten Alhede; Peter Ø Jensen; Claus Moser; Thomas Scheike; Carsten S Jacobsen; Steen Seier Poulsen; Steffen Robert Eickhardt-Sørensen; Hannah Trøstrup; Lars Christoffersen; Hans-Petter Hougen; Lars F Rickelt; Michael Kühl; Niels Høiby; Thomas Bjarnsholt
Journal:  Infect Immun       Date:  2014-08-11       Impact factor: 3.441

2.  The phagocytic fitness of leucopatches may impact the healing of chronic wounds.

Authors:  K Thomsen; H Trøstrup; L Christophersen; R Lundquist; N Høiby; C Moser
Journal:  Clin Exp Immunol       Date:  2016-03-23       Impact factor: 4.330

3.  Diffusion Retardation by Binding of Tobramycin in an Alginate Biofilm Model.

Authors:  Bao Cao; Lars Christophersen; Mette Kolpen; Peter Østrup Jensen; Kim Sneppen; Niels Høiby; Claus Moser; Thomas Sams
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

4.  Pseudomonas aeruginosa Aggregate Formation in an Alginate Bead Model System Exhibits In Vivo-Like Characteristics.

Authors:  Majken Sønderholm; Kasper Nørskov Kragh; Klaus Koren; Tim Holm Jakobsen; Sophie E Darch; Maria Alhede; Peter Østrup Jensen; Marvin Whiteley; Michael Kühl; Thomas Bjarnsholt
Journal:  Appl Environ Microbiol       Date:  2017-04-17       Impact factor: 4.792

5.  Development of Pseudomonas aeruginosa Biofilms in Partial-Thickness Burn Wounds Using a Sprague-Dawley Rat Model.

Authors:  Kenneth S Brandenburg; Alan J Weaver; Liwu Qian; Tao You; Ping Chen; S L Rajasekhar Karna; Andrea B Fourcaudot; Eliza A Sebastian; Johnathan J Abercrombie; Uzziel Pineda; Jinson Hong; Nathan A Wienandt; Kai P Leung
Journal:  J Burn Care Res       Date:  2019-01-01       Impact factor: 1.845

6.  Adjunctive S100A8/A9 Immunomodulation Hinders Ciprofloxacin Resistance in Pseudomonas aeruginosa in a Murine Biofilm Wound Model.

Authors:  Anne S Laulund; Franziska Schwartz; Hannah Trøstrup; Kim Thomsen; Lars Christophersen; Henrik Calum; Oana Ciofu; Niels Høiby; Claus Moser
Journal:  Front Cell Infect Microbiol       Date:  2021-04-12       Impact factor: 5.293

7.  Non-thermal plasma causes Pseudomonas aeruginosa biofilm release to planktonic form and inhibits production of Las-B elastase, protease and pyocyanin.

Authors:  Petra Kašparová; Eva Vaňková; Martina Paldrychová; Alžběta Svobodová; Romana Hadravová; Irena Jarošová Kolouchová; Jan Masák; Vladimir Scholtz
Journal:  Front Cell Infect Microbiol       Date:  2022-09-23       Impact factor: 6.073

8.  Chicken IgY reduces the risk of Pseudomonas aeruginosa urinary tract infections in a murine model.

Authors:  Franziska A Schwartz; Lars Christophersen; Kim Thomsen; Sarah Baekdal; Maria Pals Bendixen; Mette Jørgensen; Ida Kirstine Bull Rasmussen; Anne Sofie Laulund; Niels Høiby; Claus Moser
Journal:  Front Microbiol       Date:  2022-09-09       Impact factor: 6.064

9.  Mapping the tail fiber as the receptor binding protein responsible for differential host specificity of Pseudomonas aeruginosa bacteriophages PaP1 and JG004.

Authors:  Shuai Le; Xuesong He; Yinling Tan; Guangtao Huang; Lin Zhang; Renate Lux; Wenyuan Shi; Fuquan Hu
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

10.  Immune Modulating Topical S100A8/A9 Inhibits Growth of Pseudomonas aeruginosa and Mitigates Biofilm Infection in Chronic Wounds.

Authors:  Hannah Trøstrup; Christian Johann Lerche; Lars Christophersen; Peter Østrup Jensen; Niels Høiby; Claus Moser
Journal:  Int J Mol Sci       Date:  2017-06-26       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.